Embla Medical hf. (OSSUY)

-11.11% (1Y)

Market Cap	2.17B
Revenue (ttm)	857.82M
Net Income (ttm)	72.18M
Shares Out	n/a
EPS (ttm)	0.17
PE Ratio	30.06
Forward PE	26.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,501
Average Volume	587
Open	4.000
Previous Close	4.480
Day's Range	4.000 - 4.000
52-Week Range	3.760 - 11.000
Beta	0.58
RSI	46.63
Earnings Date	Jul 22, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,061
• Stock Exchange: OTCMKTS
• Ticker Symbol: OSSUY

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.